Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium-TCA induced malignant syndrome. Case report.

D De Maio1, M Laviani

  • 1Servizio di Psichiatria-Lithium Center, Hospital Fatebenefratelli-Oftalmico, Milan, Italy.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1991
PubMed
Summary

This case study details adverse reactions in a woman treated with lithium and TCAs, potentially indicating Malignant Hyperthermia (MH). Hypothalamic phospholipid liposomes (HPL) and myorelaxants may reduce these lithium side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lithium ratio, phospholipids and the incidence of side effects.

Progress in neuro-psychopharmacology & biological psychiatry·1994
Same author

[Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].

Minerva psichiatrica·1992
Same author

Clinical notes on buspirone.

Pharmacology, biochemistry, and behavior·1988
Same author

Notes on human behavioural pharmacotoxicology.

Progress in neuro-psychopharmacology & biological psychiatry·1988
Same author

Technological society: its impact on youth.

Topics in clinical nursing·1983
Same author

Evaluation of circadian, circaseptan, and circannual periodicity of attempted suicides.

Chronobiologia·1982

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Bipolar disorder management often involves lithium and tricyclic antidepressants (TCAs).
  • Adverse drug reactions can complicate treatment, necessitating careful monitoring.
  • Malignant Hyperthermia (MH) is a rare but severe pharmacogenetic disorder.

Observation:

  • A 71-year-old woman experienced adverse reactions during treatment for mixed bipolar disorder.
  • Symptoms were consistent with a diagnosis of Malignant Hyperthermia (MH).
  • The patient was administered lithium and TCAs.

Findings:

  • The described adverse events align with Malignant Hyperthermia (MH) triggered by lithium and TCA administration.
  • The study explores the potential efficacy of hypothalamic phospholipid liposomes (HPL) in mitigating these side effects.

Related Experiment Videos

  • Co-administration of HPL and myorelaxants is investigated as a therapeutic strategy.

    • Implications:

    • This case highlights the importance of recognizing Malignant Hyperthermia (MH) in patients on lithium and TCAs.
    • Hypothalamic phospholipid liposomes (HPL) may offer a novel approach to managing lithium-induced side effects.
    • Further research is warranted to validate the use of HPL in preventing or treating drug-induced hyperthermia.